These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11521079)

  • 1. Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
    Opal SM; Palardy JE; Parejo N; Morrison DC
    J Endotoxin Res; 2001; 7(1):35-8. PubMed ID: 11521079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria.
    David SA; Silverstein R; Amura CR; Kielian T; Morrison DC
    Antimicrob Agents Chemother; 1999 Apr; 43(4):912-9. PubMed ID: 10103199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
    Cross AS; Opal SM; Warren HS; Palardy JE; Glaser K; Parejo NA; Bhattacharjee AK
    J Infect Dis; 2001 Apr; 183(7):1079-86. PubMed ID: 11237833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
    Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
    Mészáros J; Tołłoczko T; Stachlewska E; Tyc Z; Jeljaszewicz J
    J Chemother; 1989 Jul; 1(4 Suppl):828-9. PubMed ID: 16312658
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models.
    Hubsch AP; Casas AT; Doran JE
    J Lab Clin Med; 1995 Dec; 126(6):548-58. PubMed ID: 7490514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally administered recombinant human interleukin-11 is protective in experimental neutropenic sepsis.
    Opal SM; Keith JC; Jhung J; Palardy JE; Parejo N; Marchese E; Maganti V
    J Infect Dis; 2003 Jan; 187(1):70-6. PubMed ID: 12508148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study of the LPS release from gram-negative bacteria induced by antibiotics (Part two)].
    Xu N; Yuan J; Xiao G; Zheng J; Qin X
    Zhonghua Shao Shang Za Zhi; 2002 Apr; 18(2):92-4. PubMed ID: 12515654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of reconstituted high-density lipoprotein in persistent gram-negative bacteremia.
    Casas AT; Hubsch AP; Doran JE
    Am Surg; 1996 May; 62(5):350-5. PubMed ID: 8615560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does antibiotic selection impact patient outcome?
    Harbarth S; Nobre V; Pittet D
    Clin Infect Dis; 2007 Jan; 44(1):87-93. PubMed ID: 17143822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of egg white lysozyme on ceftazidime-induced release of endotoxin from Pseudomonas aeruginosa].
    Liang AH; Xue BY; Liang RX; Wang JH; Wang D
    Yao Xue Xue Bao; 2003 Nov; 38(11):801-4. PubMed ID: 14991988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
    Opal SM; Palardy JE; Parejo N; Jasman RL
    Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adjunctive treatment with gamma interferon against Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 Sep; 24(3):219-25. PubMed ID: 15325424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
    Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
    J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.